Global Aluminum Adjuvanted Vaccines Market Growth 2023-2029

Global Aluminum Adjuvanted Vaccines Market Growth 2023-2029


The global Aluminum Adjuvanted Vaccines market size is projected to grow from US$ 635.9 million in 2022 to US$ 1211.6 million in 2029; it is expected to grow at a CAGR of 9.6% from 2023 to 2029.

Vaccination programs are essential for the prevention of infectious diseases, and aluminum adjuvanted vaccines play an important role in many immunization programs. Rising awareness regarding the importance of vaccination and expanding vaccination programs across the globe is boosting the demand for aluminum adjuvanted vaccines.

The mechanism of action of aluminum adjuvant mainly includes storage effect and immunostimulatory effect. Aluminum adjuvant can also stimulate innate immunity and induce monocytes to secrete IL-1β and IL-18 by activating Nlrp3 inflammasome. In addition, aluminum adjuvant can stimulate necrotic cells at the injection site to release damage-associated pattern molecules (DAMPs) such as DNA, ATP, and uric acid, and the released DAMPs help the interaction between dendritic cells and CD4+ T cells.

LPI (LP Information)' newest research report, the “Aluminum Adjuvanted Vaccines Industry Forecast” looks at past sales and reviews total world Aluminum Adjuvanted Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Aluminum Adjuvanted Vaccines sales for 2023 through 2029. With Aluminum Adjuvanted Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aluminum Adjuvanted Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Aluminum Adjuvanted Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aluminum Adjuvanted Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Aluminum Adjuvanted Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aluminum Adjuvanted Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aluminum Adjuvanted Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Aluminum Adjuvanted Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Aluminum Phosphate
Aluminum Hydroxide
Potassium Aluminum Sulfate

Segmentation by application
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Emergent BioSolutions
Sanofi
GlaxoSmithKline Biologicals
Pfizer
Merck
Wyeth Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Aluminum Adjuvanted Vaccines market?

What factors are driving Aluminum Adjuvanted Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Aluminum Adjuvanted Vaccines market opportunities vary by end market size?

How does Aluminum Adjuvanted Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aluminum Adjuvanted Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Aluminum Adjuvanted Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Aluminum Adjuvanted Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Aluminum Adjuvanted Vaccines Segment by Type
2.2.1 Aluminum Phosphate
2.2.2 Aluminum Hydroxide
2.2.3 Potassium Aluminum Sulfate
2.3 Aluminum Adjuvanted Vaccines Sales by Type
2.3.1 Global Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Aluminum Adjuvanted Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Aluminum Adjuvanted Vaccines Sale Price by Type (2018-2023)
2.4 Aluminum Adjuvanted Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Aluminum Adjuvanted Vaccines Sales by Application
2.5.1 Global Aluminum Adjuvanted Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Aluminum Adjuvanted Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Aluminum Adjuvanted Vaccines Sale Price by Application (2018-2023)
3 Global Aluminum Adjuvanted Vaccines by Company
3.1 Global Aluminum Adjuvanted Vaccines Breakdown Data by Company
3.1.1 Global Aluminum Adjuvanted Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Aluminum Adjuvanted Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Aluminum Adjuvanted Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Aluminum Adjuvanted Vaccines Revenue by Company (2018-2023)
3.2.2 Global Aluminum Adjuvanted Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Aluminum Adjuvanted Vaccines Sale Price by Company
3.4 Key Manufacturers Aluminum Adjuvanted Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aluminum Adjuvanted Vaccines Product Location Distribution
3.4.2 Players Aluminum Adjuvanted Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Aluminum Adjuvanted Vaccines by Geographic Region
4.1 World Historic Aluminum Adjuvanted Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Aluminum Adjuvanted Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Aluminum Adjuvanted Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Aluminum Adjuvanted Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Aluminum Adjuvanted Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Aluminum Adjuvanted Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Aluminum Adjuvanted Vaccines Sales Growth
4.4 APAC Aluminum Adjuvanted Vaccines Sales Growth
4.5 Europe Aluminum Adjuvanted Vaccines Sales Growth
4.6 Middle East & Africa Aluminum Adjuvanted Vaccines Sales Growth
5 Americas
5.1 Americas Aluminum Adjuvanted Vaccines Sales by Country
5.1.1 Americas Aluminum Adjuvanted Vaccines Sales by Country (2018-2023)
5.1.2 Americas Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023)
5.2 Americas Aluminum Adjuvanted Vaccines Sales by Type
5.3 Americas Aluminum Adjuvanted Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aluminum Adjuvanted Vaccines Sales by Region
6.1.1 APAC Aluminum Adjuvanted Vaccines Sales by Region (2018-2023)
6.1.2 APAC Aluminum Adjuvanted Vaccines Revenue by Region (2018-2023)
6.2 APAC Aluminum Adjuvanted Vaccines Sales by Type
6.3 APAC Aluminum Adjuvanted Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aluminum Adjuvanted Vaccines by Country
7.1.1 Europe Aluminum Adjuvanted Vaccines Sales by Country (2018-2023)
7.1.2 Europe Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023)
7.2 Europe Aluminum Adjuvanted Vaccines Sales by Type
7.3 Europe Aluminum Adjuvanted Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aluminum Adjuvanted Vaccines by Country
8.1.1 Middle East & Africa Aluminum Adjuvanted Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Aluminum Adjuvanted Vaccines Sales by Type
8.3 Middle East & Africa Aluminum Adjuvanted Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aluminum Adjuvanted Vaccines
10.3 Manufacturing Process Analysis of Aluminum Adjuvanted Vaccines
10.4 Industry Chain Structure of Aluminum Adjuvanted Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aluminum Adjuvanted Vaccines Distributors
11.3 Aluminum Adjuvanted Vaccines Customer
12 World Forecast Review for Aluminum Adjuvanted Vaccines by Geographic Region
12.1 Global Aluminum Adjuvanted Vaccines Market Size Forecast by Region
12.1.1 Global Aluminum Adjuvanted Vaccines Forecast by Region (2024-2029)
12.1.2 Global Aluminum Adjuvanted Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aluminum Adjuvanted Vaccines Forecast by Type
12.7 Global Aluminum Adjuvanted Vaccines Forecast by Application
13 Key Players Analysis
13.1 Emergent BioSolutions
13.1.1 Emergent BioSolutions Company Information
13.1.2 Emergent BioSolutions Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.1.3 Emergent BioSolutions Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Emergent BioSolutions Main Business Overview
13.1.5 Emergent BioSolutions Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GlaxoSmithKline Biologicals
13.3.1 GlaxoSmithKline Biologicals Company Information
13.3.2 GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Biologicals Main Business Overview
13.3.5 GlaxoSmithKline Biologicals Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.5.3 Merck Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Wyeth Pharmaceuticals
13.6.1 Wyeth Pharmaceuticals Company Information
13.6.2 Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.6.3 Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Wyeth Pharmaceuticals Main Business Overview
13.6.5 Wyeth Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings